APA

Radulescu E., Ganeshan B., Minati L., Beacher F. D. C. C., Gray M. A., Chatwin C., Young R. C. D., Harrison N. A. & Critchley H. D. (20131025). Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome. : The pharmacogenomics journal.

Chicago

Radulescu E, Ganeshan B, Minati L, Beacher F D C C, Gray M A, Chatwin C, Young R C D, Harrison N A and Critchley H D. 20131025. Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome. : The pharmacogenomics journal.

Harvard

Radulescu E., Ganeshan B., Minati L., Beacher F. D. C. C., Gray M. A., Chatwin C., Young R. C. D., Harrison N. A. and Critchley H. D. (20131025). Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome. : The pharmacogenomics journal.

MLA

Radulescu E, Ganeshan B, Minati L, Beacher F D C C, Gray M A, Chatwin C, Young R C D, Harrison N A and Critchley H D. Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome. : The pharmacogenomics journal. 20131025.